Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Functionalization of phosphocalcic bioceramics for bone repair applications.

Damia C, Marchat D, Lemoine C, Douard N, Chaleix V, Sol V, Larochette N, Logeart-Avramoglou D, Brie J, Champion E.

Mater Sci Eng C Mater Biol Appl. 2019 Feb 1;95:343-354. doi: 10.1016/j.msec.2018.01.008. Epub 2018 Jan 31.

PMID:
30573258
2.

The paracrine effects of human induced pluripotent stem cells promote bone-like structures via the upregulation of BMP expression in a mouse ectopic model.

Oudina K, Paquet J, Moya A, Massourides E, Bensidhoum M, Larochette N, Deschepper M, Pinset C, Petite H.

Sci Rep. 2018 Nov 20;8(1):17106. doi: 10.1038/s41598-018-35546-6.

3.

Effect of the Bone Morphogenetic Protein-2 Doses on the Osteogenic Potential of Human Multipotent Stromal Cells- Containing Tissue Engineered Constructs.

Decambron A, Devriendt N, Larochette N, Manassero M, Bourguignon M, El-Hafci H, Petite H, Viateau V, Logeart-Avramoglou D.

Tissue Eng Part A. 2019 Apr;25(7-8):642-651. doi: 10.1089/ten.TEA.2018.0146. Epub 2018 Nov 9.

PMID:
30311857
4.

Human Mesenchymal Stem Cell Failure to Adapt to Glucose Shortage and Rapidly Use Intracellular Energy Reserves Through Glycolysis Explains Poor Cell Survival After Implantation.

Moya A, Paquet J, Deschepper M, Larochette N, Oudina K, Denoeud C, Bensidhoum M, Logeart-Avramoglou D, Petite H.

Stem Cells. 2018 Mar;36(3):363-376. doi: 10.1002/stem.2763. Epub 2018 Jan 9.

5.

Osteogenic potential of adipogenic predifferentiated human bone marrow-derived multipotent stromal cells for bone tissue-engineering.

Moya A, Larochette N, Bourguignon M, El-Hafci H, Potier E, Petite H, Logeart-Avramoglou D.

J Tissue Eng Regen Med. 2018 Mar;12(3):e1511-e1524. doi: 10.1002/term.2571. Epub 2017 Nov 28.

PMID:
28875591
6.

Quiescence Preconditioned Human Multipotent Stromal Cells Adopt a Metabolic Profile Favorable for Enhanced Survival under Ischemia.

Moya A, Larochette N, Paquet J, Deschepper M, Bensidhoum M, Izzo V, Kroemer G, Petite H, Logeart-Avramoglou D.

Stem Cells. 2017 Jan;35(1):181-196. doi: 10.1002/stem.2493. Epub 2016 Sep 21.

7.

Cdc42 controls the dilation of the exocytotic fusion pore by regulating membrane tension.

Bretou M, Jouannot O, Fanget I, Pierobon P, Larochette N, Gestraud P, Guillon M, Emiliani V, Gasman S, Desnos C, Lennon-Duménil AM, Darchen F.

Mol Biol Cell. 2014 Oct 15;25(20):3195-209. doi: 10.1091/mbc.E14-07-1229. Epub 2014 Aug 20.

8.

Myrip couples the capture of secretory granules by the actin-rich cell cortex and their attachment to the plasma membrane.

Huet S, Fanget I, Jouannot O, Meireles P, Zeiske T, Larochette N, Darchen F, Desnos C.

J Neurosci. 2012 Feb 15;32(7):2564-77. doi: 10.1523/JNEUROSCI.2724-11.2012.

9.

Polarized secretion of lysosomes at the B cell synapse couples antigen extraction to processing and presentation.

Yuseff MI, Reversat A, Lankar D, Diaz J, Fanget I, Pierobon P, Randrian V, Larochette N, Vascotto F, Desdouets C, Jauffred B, Bellaiche Y, Gasman S, Darchen F, Desnos C, Lennon-Duménil AM.

Immunity. 2011 Sep 23;35(3):361-74. doi: 10.1016/j.immuni.2011.07.008. Epub 2011 Aug 4.

10.

Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease.

Zischka H, Lichtmannegger J, Schmitt S, Jägemann N, Schulz S, Wartini D, Jennen L, Rust C, Larochette N, Galluzzi L, Chajes V, Bandow N, Gilles VS, DiSpirito AA, Esposito I, Goettlicher M, Summer KH, Kroemer G.

J Clin Invest. 2011 Apr;121(4):1508-18. doi: 10.1172/JCI45401.

11.

Electrophoretic analysis of the mitochondrial outer membrane rupture induced by permeability transition.

Zischka H, Larochette N, Hoffmann F, Hamöller D, Jägemann N, Lichtmannegger J, Jennen L, Müller-Höcker J, Roggel F, Göttlicher M, Vollmar AM, Kroemer G.

Anal Chem. 2008 Jul 1;80(13):5051-8. doi: 10.1021/ac800173r. Epub 2008 May 30.

PMID:
18510346
12.

Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death.

Tajeddine N, Galluzzi L, Kepp O, Hangen E, Morselli E, Senovilla L, Araujo N, Pinna G, Larochette N, Zamzami N, Modjtahedi N, Harel-Bellan A, Kroemer G.

Oncogene. 2008 Jul 10;27(30):4221-32. doi: 10.1038/onc.2008.63. Epub 2008 Mar 24.

PMID:
18362892
13.

Unexpected role of the phosphate carrier in mitochondrial fragmentation.

Pauleau AL, Galluzzi L, Scholz SR, Larochette N, Kepp O, Kroemer G.

Cell Death Differ. 2008 Mar;15(3):616-8. doi: 10.1038/sj.cdd.4402295. Epub 2008 Jan 4. No abstract available.

14.

Structure-function analysis of the interaction between Bax and the cytomegalovirus-encoded protein vMIA.

Pauleau AL, Larochette N, Giordanetto F, Scholz SR, Poncet D, Zamzami N, Goldmacher VS, Kroemer G.

Oncogene. 2007 Nov 1;26(50):7067-80. Epub 2007 May 14.

PMID:
17496930
15.

Calreticulin exposure dictates the immunogenicity of cancer cell death.

Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, Castedo M, Mignot G, Panaretakis T, Casares N, Métivier D, Larochette N, van Endert P, Ciccosanti F, Piacentini M, Zitvogel L, Kroemer G.

Nat Med. 2007 Jan;13(1):54-61. Epub 2006 Dec 24.

PMID:
17187072
16.

GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization.

Tarze A, Deniaud A, Le Bras M, Maillier E, Molle D, Larochette N, Zamzami N, Jan G, Kroemer G, Brenner C.

Oncogene. 2007 Apr 19;26(18):2606-20. Epub 2006 Oct 30.

PMID:
17072346
17.

Mitochondria as therapeutic targets for cancer chemotherapy.

Galluzzi L, Larochette N, Zamzami N, Kroemer G.

Oncogene. 2006 Aug 7;25(34):4812-30. Review.

PMID:
16892093
18.

hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway.

Massard C, Zermati Y, Pauleau AL, Larochette N, Métivier D, Sabatier L, Kroemer G, Soria JC.

Oncogene. 2006 Aug 3;25(33):4505-14. Epub 2006 Apr 17. Erratum in: Oncogene. 2013 Jan 24;32(4):536.

PMID:
16619047
19.

Mitochondrial permeability transition in apoptosis and necrosis.

Zamzami N, Larochette N, Kroemer G.

Cell Death Differ. 2005 Nov;12 Suppl 2:1478-80. No abstract available.

20.

PK11195 potently sensitizes to apoptosis induction independently from the peripheral benzodiazepin receptor.

Gonzalez-Polo RA, Carvalho G, Braun T, Decaudin D, Fabre C, Larochette N, Perfettini JL, Djavaheri-Mergny M, Youlyouz-Marfak I, Codogno P, Raphael M, Feuillard J, Kroemer G.

Oncogene. 2005 Nov 17;24(51):7503-13.

PMID:
16091749
21.

The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death.

González-Polo RA, Boya P, Pauleau AL, Jalil A, Larochette N, Souquère S, Eskelinen EL, Pierron G, Saftig P, Kroemer G.

J Cell Sci. 2005 Jul 15;118(Pt 14):3091-102. Epub 2005 Jun 28.

22.

Inhibition of macroautophagy triggers apoptosis.

Boya P, González-Polo RA, Casares N, Perfettini JL, Dessen P, Larochette N, Métivier D, Meley D, Souquere S, Yoshimori T, Pierron G, Codogno P, Kroemer G.

Mol Cell Biol. 2005 Feb;25(3):1025-40.

23.

[The fight against smoking. Efficacy of measures against societal factors].

Mélihan-Cheinin R, Larochette N, Martin D, Basset B, Postel-Vinay N, Coquin Y, Dab W.

Rev Prat. 2004 Nov 15;54(17):1865-6. Review. French. No abstract available.

PMID:
15655908
24.

Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope.

Perfettini JL, Castedo M, Nardacci R, Ciccosanti F, Boya P, Roumier T, Larochette N, Piacentini M, Kroemer G.

J Exp Med. 2005 Jan 17;201(2):279-89. Epub 2005 Jan 10.

25.

AIF deficiency compromises oxidative phosphorylation.

Vahsen N, Candé C, Brière JJ, Bénit P, Joza N, Larochette N, Mastroberardino PG, Pequignot MO, Casares N, Lazar V, Feraud O, Debili N, Wissing S, Engelhardt S, Madeo F, Piacentini M, Penninger JM, Schägger H, Rustin P, Kroemer G.

EMBO J. 2004 Nov 24;23(23):4679-89. Epub 2004 Nov 4.

26.

Preapoptotic chromatin condensation upstream of the mitochondrial checkpoint.

Andreau K, Castedo M, Perfettini JL, Roumier T, Pichart E, Souquere S, Vivet S, Larochette N, Kroemer G.

J Biol Chem. 2004 Dec 31;279(53):55937-45. Epub 2004 Oct 21.

27.

An anti-apoptotic viral protein that recruits Bax to mitochondria.

Poncet D, Larochette N, Pauleau AL, Boya P, Jalil AA, Cartron PF, Vallette F, Schnebelen C, Bartle LM, Skaletskaya A, Boutolleau D, Martinou JC, Goldmacher VS, Kroemer G, Zamzami N.

J Biol Chem. 2004 May 21;279(21):22605-14. Epub 2004 Mar 5.

28.

NF-kappaB and p53 are the dominant apoptosis-inducing transcription factors elicited by the HIV-1 envelope.

Perfettini JL, Roumier T, Castedo M, Larochette N, Boya P, Raynal B, Lazar V, Ciccosanti F, Nardacci R, Penninger J, Piacentini M, Kroemer G.

J Exp Med. 2004 Mar 1;199(5):629-40.

29.

Palmitate induces apoptosis via a direct effect on mitochondria.

de Pablo MA, Susin SA, Jacotot E, Larochette N, Costantini P, Ravagnan L, Zamzami N, Kroemer G.

Apoptosis. 1999 Apr;4(2):81-7.

PMID:
14634285
30.

The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family.

Boya P, Morales MC, Gonzalez-Polo RA, Andreau K, Gourdier I, Perfettini JL, Larochette N, Deniaud A, Baran-Marszak F, Fagard R, Feuillard J, Asumendi A, Raphael M, Pau B, Brenner C, Kroemer G.

Oncogene. 2003 Sep 18;22(40):6220-30.

PMID:
13679861
31.

DNA binding is required for the apoptogenic action of apoptosis inducing factor.

Ye H, Cande C, Stephanou NC, Jiang S, Gurbuxani S, Larochette N, Daugas E, Garrido C, Kroemer G, Wu H.

Nat Struct Biol. 2002 Sep;9(9):680-4.

PMID:
12198487
32.

Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria.

Candé C, Cohen I, Daugas E, Ravagnan L, Larochette N, Zamzami N, Kroemer G.

Biochimie. 2002 Feb-Mar;84(2-3):215-22. Review.

PMID:
12022952
33.

Wild-type p53 induced sensitization of mutant p53 TNF-resistant cells: role of caspase-8 and mitochondria.

Ameyar-Zazoua M, Larochette N, Dorothée G, Daugas E, Haddada H, Gouloumet V, Métivier D, Stancou R, Mami-Chouaib F, Kroemer G, Chouaib S.

Cancer Gene Ther. 2002 Mar;9(3):219-27.

34.

Human immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target of rapamycin/FKBP12-rapamycin-associated protein-mediated p53 phosphorylation.

Castedo M, Ferri KF, Blanco J, Roumier T, Larochette N, Barretina J, Amendola A, Nardacci R, Métivier D, Este JA, Piacentini M, Kroemer G.

J Exp Med. 2001 Oct 15;194(8):1097-110.

35.

Purification of mitochondria for apoptosis assays.

Susin SA, Larochette N, Geuskens M, Kroemer G.

Methods Enzymol. 2000;322:205-8. No abstract available.

PMID:
10914017
36.

Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis.

Daugas E, Susin SA, Zamzami N, Ferri KF, Irinopoulou T, Larochette N, Prévost MC, Leber B, Andrews D, Penninger J, Kroemer G.

FASEB J. 2000 Apr;14(5):729-39.

PMID:
10744629
37.

Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis.

Costantini P, Belzacq AS, Vieira HL, Larochette N, de Pablo MA, Zamzami N, Susin SA, Brenner C, Kroemer G.

Oncogene. 2000 Jan 13;19(2):307-14.

38.

Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore.

Larochette N, Decaudin D, Jacotot E, Brenner C, Marzo I, Susin SA, Zamzami N, Xie Z, Reed J, Kroemer G.

Exp Cell Res. 1999 Jun 15;249(2):413-21.

PMID:
10366441
39.

Molecular characterization of mitochondrial apoptosis-inducing factor.

Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G.

Nature. 1999 Feb 4;397(6718):441-6.

PMID:
9989411
40.

Mitochondrial release of caspase-2 and -9 during the apoptotic process.

Susin SA, Lorenzo HK, Zamzami N, Marzo I, Brenner C, Larochette N, Prévost MC, Alzari PM, Kroemer G.

J Exp Med. 1999 Jan 18;189(2):381-94.

41.

Cytofluorometric detection of mitochondrial alterations in early CD95/Fas/APO-1-triggered apoptosis of Jurkat T lymphoma cells. Comparison of seven mitochondrion-specific fluorochromes.

Métivier D, Dallaporta B, Zamzami N, Larochette N, Susin SA, Marzo I, Kroemer G.

Immunol Lett. 1998 Apr;61(2-3):157-63.

PMID:
9657269
42.

PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection.

Hirsch T, Decaudin D, Susin SA, Marchetti P, Larochette N, Resche-Rigon M, Kroemer G.

Exp Cell Res. 1998 Jun 15;241(2):426-34.

PMID:
9637784
43.

Caspases disrupt mitochondrial membrane barrier function.

Marzo I, Susin SA, Petit PX, Ravagnan L, Brenner C, Larochette N, Zamzami N, Kroemer G.

FEBS Lett. 1998 May 8;427(2):198-202.

44.

Potassium leakage during the apoptotic degradation phase.

Dallaporta B, Hirsch T, Susin SA, Zamzami N, Larochette N, Brenner C, Marzo I, Kroemer G.

J Immunol. 1998 Jun 1;160(11):5605-15.

45.

The thiol crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transition.

Zamzami N, Marzo I, Susin SA, Brenner C, Larochette N, Marchetti P, Reed J, Kofler R, Kroemer G.

Oncogene. 1998 Feb 26;16(8):1055-63.

46.

A cytofluorometric assay of nuclear apoptosis induced in a cell-free system: application to ceramide-induced apoptosis.

Susin SA, Zamzami N, Larochette N, Dallaporta B, Marzo I, Brenner C, Hirsch T, Petit PX, Geuskens M, Kroemer G.

Exp Cell Res. 1997 Nov 1;236(2):397-403.

PMID:
9367623

Supplemental Content

Loading ...
Support Center